Bilaketaren emaitzak - Daniel Rauh

Findu emaitzak
  1. 1
    Hope and Disappointment: Covalent Inhibitors to Overcome Drug Resistance in Non-Small Cell Lung Cancer

    Hope and Disappointment: Covalent Inhibitors to Overcome Drug Resistance in Non-Small Cell Lung Cancer nork Julian Engel, Jonas Lategahn, Daniel Rauh

    Argitaratua 2015
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  2. 2
    C797S Resistance: The Undruggable EGFR Mutation in Non-Small Cell Lung Cancer?

    C797S Resistance: The Undruggable EGFR Mutation in Non-Small Cell Lung Cancer? nork Tobias Grabe, Jonas Lategahn, Daniel Rauh

    Argitaratua 2018
    Testu osoa Testu osoa
    Editorial
    Gogokoenen artean sartu
    Gorde:
  3. 3
    Spotlight on AKT: Current Therapeutic Challenges

    Spotlight on AKT: Current Therapeutic Challenges nork Ina Landel, Lena Quambusch, Laura Depta, Daniel Rauh

    Argitaratua 2020
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  4. 4
    KRasG12C inhibitors in clinical trials: a short historical perspective

    KRasG12C inhibitors in clinical trials: a short historical perspective nork Lisa Goebel, Matthias Müller, Roger S. Goody, Daniel Rauh

    Argitaratua 2020
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  5. 5
    Human Carbonyl Reductase 1 Is an S-Nitrosoglutathione Reductase

    Human Carbonyl Reductase 1 Is an S-Nitrosoglutathione Reductase nork Raynard L. Bateman, Daniel Rauh, Brandon Tavshanjian, Kevan M. Shokat

    Argitaratua 2008
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  6. 6
    Complex Crystal Structures of EGFR with Third-Generation Kinase Inhibitors and Simultaneously Bound Allosteric Ligands

    Complex Crystal Structures of EGFR with Third-Generation Kinase Inhibitors and Simultaneously Bound Allosteric Ligands nork Janina Niggenaber, Leonie Heyden, Tobias Grabe, Matthias Müller, Jonas Lategahn, Daniel Rauh

    Argitaratua 2020
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  7. 7
    Proteus in the World of Proteins: Conformational Changes in Protein Kinases

    Proteus in the World of Proteins: Conformational Changes in Protein Kinases nork Matthias Rabiller, Matthäus Getlik, Sabine Klüter, André Richters, Sandra Tückmantel, Jeffrey R. Simard, Daniel Rauh

    Argitaratua 2010
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  8. 8
    Identification and Further Development of Potent TBK1 Inhibitors

    Identification and Further Development of Potent TBK1 Inhibitors nork André Richters, Debjit Basu, Julian Engel, Meryem S. Ercanoglu, Hyatt Balke‐Want, Roberta Tesch, Roman K. Thomas, Daniel Rauh

    Argitaratua 2014
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  9. 9
    Highly Enantioselective Catalytic Synthesis of Neurite Growth-Promoting Secoyohimbanes

    Highly Enantioselective Catalytic Synthesis of Neurite Growth-Promoting Secoyohimbanes nork Andrey P. Antonchick, S. López-Tosco, Juan A. Parga, Sonja Sievers, Markus Schürmann, Hans Preut, Susanne Höing, Hans R. Schöler, Jared Sterneckert, Daniel Rauh, Herbert Waldmann

    Argitaratua 2013
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  10. 10
    An Unbiased Cell Morphology–Based Screen for New, Biologically Active Small Molecules

    An Unbiased Cell Morphology–Based Screen for New, Biologically Active Small Molecules nork Masahiro Tanaka, Raynard L. Bateman, Daniel Rauh, Eugeni Vaisberg, Shyam Ramachandani, Chao Zhang, Kirk C. Hansen, Alma L. Burlingame, J. K. Trautman, Kevan M. Shokat, Cynthia L. Adams

    Argitaratua 2005
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  11. 11
    A novel scaffold for EGFR inhibition: Introducing N-(3-(3-phenylureido)quinoxalin-6-yl) acrylamide derivatives

    A novel scaffold for EGFR inhibition: Introducing N-(3-(3-phenylureido)quinoxalin-6-yl) acrylamide derivatives nork Daniel N. do Amaral, Jonas Lategahn, Harold Hilarion Fokoue, Eduardo Miguez Bastos da Silva, Carlos Maurício R. Sant’Anna, Daniel Rauh, Eliezer J. Barreiro, Stefan Laufer, Lı́dia Moreira Lima

    Argitaratua 2019
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  12. 12
    Avapritinib-based SAR studies unveil a binding pocket in KIT and PDGFRA

    Avapritinib-based SAR studies unveil a binding pocket in KIT and PDGFRA nork Alina Teuber, Tom Schulz, B. S. Fletcher, Rajesh Gontla, Thomas Mühlenberg, Mia‐Lisa Zischinsky, Janina Niggenaber, Jörn Weisner, Silke Kleinbölting, Jonas Lategahn, Sonja Sievers, Matthias Müller, Sebastian Bauer, Daniel Rauh

    Argitaratua 2024
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  13. 13
    ALK Mutations Conferring Differential Resistance to Structurally Diverse ALK Inhibitors

    ALK Mutations Conferring Differential Resistance to Structurally Diverse ALK Inhibitors nork Johannes M. Heuckmann, Michael Hölzel, Martin L. Sos, Stefanie Heynck, Hyatt Balke‐Want, Mirjam Koker, Martin Peifer, Jonathan M. Weiss, Christine M. Lovly, Christian Grütter, Daniel Rauh, William Pao, Roman K. Thomas

    Argitaratua 2011
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  14. 14
    Phenotypic Identification of a Novel Autophagy Inhibitor Chemotype Targeting Lipid Kinase VPS34

    Phenotypic Identification of a Novel Autophagy Inhibitor Chemotype Targeting Lipid Kinase VPS34 nork Lucas Robke, Luca Laraia, Marjorie A. Carnero Corrales, Georgios Konstantinidis, Makoto Muroi, André Richters, Michael Winzker, Tobias Engbring, Stefano Tomassi, Nobumoto Watanabe, Hiroyuki Osada, Daniel Rauh, Herbert Waldmann, Yao‐Wen Wu, Julian Engel

    Argitaratua 2017
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  15. 15
    Structural and chemical insights into the covalent-allosteric inhibition of the protein kinase Akt

    Structural and chemical insights into the covalent-allosteric inhibition of the protein kinase Akt nork Niklas Uhlenbrock, Steven P. Smith, Jörn Weisner, Ina Landel, Marius Lindemann, Thien Anh Le, Julia Hardick, Rajesh Gontla, Rebekka Scheinpflug, Paul Czodrowski, Petra Janning, Laura Depta, Lena Quambusch, Matthias Müller, Bernd Engels, Daniel Rauh

    Argitaratua 2019
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  16. 16
    Tumor VEGF:VEGFR2 autocrine feed-forward loop triggers angiogenesis in lung cancer

    Tumor VEGF:VEGFR2 autocrine feed-forward loop triggers angiogenesis in lung cancer nork Sampurna Chatterjee, Lukas C. Heukamp, Maike Siobal, Jakob Schöttle, Caroline Wieczorek, Martin Peifer, Davide Frasca, Mirjam Koker, Katharina König, Lydia Meder, Daniel Rauh, Reinhard Buettner, Jürgen Wolf, Rolf A. Brekken, Bernd Neumaier, Gerhard Christofori, Roman K. Thomas, Roland T. Ullrich

    Argitaratua 2013
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  17. 17
    Resistance to Avapritinib in PDGFRA-Driven GIST Is Caused by Secondary Mutations in the PDGFRA Kinase Domain

    Resistance to Avapritinib in PDGFRA-Driven GIST Is Caused by Secondary Mutations in the PDGFRA Kinase Domain nork Susanne Grünewald, Lillian R. Klug, Thomas Mühlenberg, Jonas Lategahn, Johanna Falkenhorst, Ajia Town, Christiane Ehrt, Eva Wardelmann, Wolfgang Hartmann, Hans‐Ulrich Schildhaus, Juergen Treckmann, Jonathan A. Fletcher, Sascha Jung, Paul Czodrowski, Steven P. Miller, Oleg Schmidt-Kittler, Daniel Rauh, Michael C. Heinrich, Sebastian Bauer

    Argitaratua 2020
    Testu osoa Testu osoa
    Carta
    Gogokoenen artean sartu
    Gorde:
  18. 18
    Chemogenomic Profiling Provides Insights into the Limited Activity of Irreversible EGFR Inhibitors in Tumor Cells Expressing the T790M EGFR Resistance Mutation

    Chemogenomic Profiling Provides Insights into the Limited Activity of Irreversible EGFR Inhibitors in Tumor Cells Expressing the T790M EGFR Resistance Mutation nork Martin L. Sos, Haridas B. Rode, Stefanie Heynck, Martin Peifer, Florian Fischer, Sabine Klüter, Vijaykumar G. Pawar, Cecile Reuter, Johannes M. Heuckmann, Jonathan M. Weiss, Lars Ruddigkeit, Matthias Rabiller, Mirjam Koker, Jeffrey R. Simard, Matthäus Getlik, Yuki Yuza, Tzu-Hsiu Chen, Heidi Greulich, Roman K. Thomas, Daniel Rauh

    Argitaratua 2010
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  19. 19
    A framework for identification of actionable cancer genome dependencies in small cell lung cancer

    A framework for identification of actionable cancer genome dependencies in small cell lung cancer nork Martin L. Sos, Felix Dietlein, Martin Peifer, Jakob Schöttle, Hyatt Balke‐Want, Christian Müller, Mirjam Koker, André Richters, Stefanie Heynck, Florian Malchers, Johannes M. Heuckmann, Danila Seidel, Patrick A. Eyers, Roland T. Ullrich, Andrey P. Antonchick, Viktor V. Vintonyak, Peter M. Schneider, Takashi Ninomiya, Herbert Waldmann, Reinhard Büttner, Daniel Rauh, Lukas C. Heukamp, Roman K. Thomas

    Argitaratua 2012
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  20. 20
    A Synergistic Interaction between Chk1- and MK2 Inhibitors in KRAS-Mutant Cancer

    A Synergistic Interaction between Chk1- and MK2 Inhibitors in KRAS-Mutant Cancer nork Felix Dietlein, Bastian Kalb, Mladen Jokić, Elisa M. Noll, Alexander Strong, Lars Tharun, Luka Ozretić, Helen Künstlinger, Kato Kambartel, Winfried Randerath, Christian Jüngst, Anna Schmitt, Alessandro Torgovnick, André Richters, Daniel Rauh, Florian Siedek, Thorsten Persigehl, Cornelia Mauch, Jiřina Bártková, Allan Bradley, Martin R. Sprick, Andreas Trumpp, Roland Rad, Dieter Saur, Jiří Bártek, Jürgen Wolf, Reinhard Büttner, Roman K. Thomas, Hans Christian Reinhardt

    Argitaratua 2015
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:

Bilaketa egiteko lanabesak: